Market-Moving News for June 29th
RNXT: 57% | RenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic Cancer JOBY: 21.5% | Joby
RenovoRx Announces Late-Breaking Oral Presentation At 2023 ESMO World Congress On Gastrointestinal Cancer
Company to Present Interim Analysis Secondary Endpoint Data Including Progression-free Survival from Phase III TIGeR-PaC Study, a Multi-center Open-label Study Evaluating RenovoGem™ to Treat Locally Advanced
RenovoRx Reports Q1 2023 Financial Results And Operational Highlights; Cash And Cash Equivalents As Of March 31, 2023, Were $3.7M
Operational Highlights for the First Quarter Ended March 31, 2023:
Announced positive new data from Phase III clinical trial interim analysis. Data suggests a 60% survival benefit and greater
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Heska (NASDAQ:HSKA) shares increased by 19.9% to $117.0 during Monday’s pre-market session. The company’s market cap stands…
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers SCYNEXIS (NASDAQ:SCYX) shares moved upwards by 66.8% to $2.79 during Thursday’s regular session. As of 13:30 EST,…
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.
RenovoRx, Inc. Announces $5M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules With A Certain Institutional Investor For The Purchase And Sale Of 1,557,632 Shares Of Common Stock At A Price Of $3.21/Share; Shares Halted On Circuit Brea…
RenovoRx, Inc. (the "Company") (NASDAQ:RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, today announced that it has entered into a definitive securities purchase agreement
US Stocks Open Higher; Dow Jumps 150 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.48% to 32,874.88 while the NASDAQ rose 0.68% to 12,007.85. The S&P 500, also rose, gaining, 0.62% to 4,052.93.
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers SCYNEXIS (NASDAQ:SCYX) shares rose 91.0% to $3.19 during Thursday’s pre-market session. The company’s market cap stands at…
RenovoRx Announces New Data From Phase III Clinical Trial Interim Analysis: 60% Survival Benefit And Fewer Side Effects Than Systemic Chemotherapy
RenovoGem™ Patients had Greater than 65% Reduction in Side Effects, which can Include Nausea, Fatigue, and Reduced White Blood Cells During Pancreatic Cancer Treatment
These Data and Additional